1,365
Views
0
CrossRef citations to date
0
Altmetric
Clinical Features - Editorial

Will the new pharmaceutical lipid-aspirin complex formulation restore the once lost trust of aspirin on cardiovascular protection?

ORCID Icon & ORCID Icon
Pages 573-575 | Received 27 Feb 2022, Accepted 24 May 2022, Published online: 31 May 2022
 

Acknowledgments

None stated.

Disclosure of any financial/other conflicts of interest

The authors have no relevant conflicts of interest to disclose. Peer reviewers of this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

The authors have no funding to report.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.